KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Sep 21, 2023 $15.67 $16.16 $15.45 $15.80 118 877
Sep 20, 2023 $16.25 $16.25 $15.77 $15.79 78 532
Sep 19, 2023 $16.28 $16.49 $15.79 $16.29 85 641
Sep 18, 2023 $15.93 $16.49 $15.53 $16.38 125 126
Sep 15, 2023 $15.78 $16.16 $15.51 $15.91 281 004
Sep 14, 2023 $15.67 $16.38 $15.66 $15.78 199 761
Sep 13, 2023 $16.21 $16.47 $15.38 $15.66 248 290
Sep 12, 2023 $16.76 $16.88 $16.06 $16.15 171 083
Sep 11, 2023 $16.66 $17.10 $16.30 $16.68 198 005
Sep 08, 2023 $16.98 $17.11 $16.38 $16.57 125 097
Sep 07, 2023 $17.88 $17.88 $16.82 $16.85 164 707
Sep 06, 2023 $17.89 $18.09 $17.17 $17.94 182 534
Sep 05, 2023 $18.14 $18.45 $17.77 $17.94 161 939
Sep 01, 2023 $17.96 $18.24 $17.69 $18.14 180 463
Aug 31, 2023 $18.39 $18.18 $17.46 $17.48 254 836
Aug 30, 2023 $18.91 $19.15 $18.06 $18.12 240 158
Aug 29, 2023 $18.31 $19.18 $18.30 $18.99 331 141
Aug 28, 2023 $18.70 $18.70 $17.86 $18.28 538 477
Aug 25, 2023 $19.27 $19.35 $18.57 $18.72 267 331
Aug 24, 2023 $19.90 $20.00 $18.84 $19.09 387 946
Aug 23, 2023 $20.49 $20.91 $19.82 $19.90 550 557
Aug 22, 2023 $20.34 $20.79 $19.70 $20.27 450 673
Aug 21, 2023 $19.04 $20.83 $18.58 $20.34 495 025
Aug 18, 2023 $18.35 $19.67 $18.35 $19.08 642 767
Aug 17, 2023 $21.48 $21.48 $17.80 $18.43 1 217 597
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT